[Comparison of efficacy between continuous positive airway pressure and renal artery sympathetic denervation by radiofrequency ablation in obstructive sleep apnea syndrome patients with hypertension].
To compare the efficacy of renal arterial sympathetic denervation (RSD) and continuous positive airway pressure (CPAP) in patients with coexisting moderate-to-severe obstructive sleep apnea syndrome (OSAS) and hypertension. Retrospective analysis was conducted for patients with coexisting moderate to severe OSAS and hypertension for the efficacy of RSD (RSD group, n = 15) and CPAP (CPAP group, n = 16). Comparison was made for polysomnographic parameters and 24 hours ambulatory blood pressure (Bp) between two groups. There was no significant difference in age, gender, body mass index, nocturnal apnea hypopnea index (AHI), mean and minimal pulse oxygen saturation (mean SpO2 and mini SpO2) between two groups. Compared with those at pre-treatment, the following changes were observed at Day 30 post-treatment: in RSD group, the nocturnal AHI and T90 statistically decreased (27 ± 14 vs 32 ± 12, 8.7% ± 7.8% vs 13.8% ± 13.1%, all P < 0.05) with a significant increase in mean SpO2 (94.3% ± 2.2% vs 93.9% ± 2.0%, P < 0.05) while mini SpO2 showed no significant difference (80.1% ± 6.2% vs 79.5% ± 4.7%, P > 0.05); in CPAP group during treatment, nocturnal AHI and the ratio of duration SpO2 < 90% to total sleep time (T90) were all significantly reduced (5 ± 3 vs 35 ± 12, 1.5% ± 1.2% vs 12.9% ± 6.3%, all P < 0.05) while mean SpO2 and mini SpO2 became significantly elevated (95.6% ± 1.4% vs 93.6% ± 1.7%, 89.2% ± 2.7% vs 79.1% ± 4.0%, all P < 0.05). Compared with RSD group, there was a significantly lower AHI (P = 0.000) but higher mean SpO2 and mini SpO2 (all P < 0.05) at Day 30 in CPAP group. At Day 30 in RSD and CPAP groups, the mean systolic blood pressure (MSBp) were (122 ± 9) and (130 ± 12) mm Hg (1 mm Hg = 0.133 kPa) respectively while the mean diastolic blood pressure (MDBp) (80 ± 8) and (83 ± 7) mm Hg respectively. All these were significantly lower than those at pre-treatment with MSBp (134 ± 20) mm Hg and MDBp (88 ± 14) mm Hg in RSD group and MSBp (136 ± 14) mm Hg and MDBp (87 ± 7) mm Hg in CPAP group. The extent of decrease in MSBp post-treatment was more remarkable in RSD group than that in CPAP group (P < 0.05). In moderate-to-severe OSAS patients with hypertension, both RSD and CPAP may improve sleep respiratory parameters and blood pressure to varying degrees. There is a more significant improvement of nocturnal AHI and SpO2 in CPAP group and more lower MSBp in RSD group.